Kessler Investment Group, LLC Abb Vie Inc. Transaction History

Kessler Investment Group, LLC

$184 Million
Q3 2024

A detailed history of Kessler Investment Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kessler Investment Group, LLC holds 1,909 shares of ABBV stock, worth $339,821. This represents 0.2% of its overall portfolio holdings.

Number of Shares

1,909

Holding current value

$339,821

% of portfolio

0.2%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$163.84 - $199.33 $312,770 - $380,520	1,909 New	1,909 $376,000
Q1 2023 Apr 14, 2023	BUY	$144.61 - $166.54 $4,193 - $4,829	29 Added 1.56%	1,888 $300,000
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $1,521 - $1,824	11 Added 0.6%	1,859 $300,000
Q3 2022 Oct 17, 2022	BUY	$134.21 - $153.93 $8,455 - $9,697	63 Added 3.53%	1,848 $248,000
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $60,690 - $77,157	-441 Reduced 19.81%	1,785 $273,000
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $1,847 - $2,292	-14 Reduced 0.63%	2,226 $361,000
Q4 2021 Feb 16, 2022	SELL	$107.43 - $135.93 $179,300 - $226,867	-1,669 Reduced 42.7%	2,240 $303,000
Q3 2021 Oct 21, 2021	SELL	$106.4 - $120.78 $22,237 - $25,243	-209 Reduced 5.08%	3,909 $422,000
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $339,828 - $378,588	3,230 Added 363.74%	4,118 $464,000
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $2,352 - $2,590	-23 Reduced 2.52%	888 $96,000
Q2 2020 Jul 21, 2020	BUY	$73.37 - $98.18 $17,608 - $23,563	240 Added 35.77%	911 $89,000
Q1 2020 Apr 22, 2020	SELL	$64.5 - $97.79 $3,676 - $5,574	-57 Reduced 7.83%	671 $51,000
Q4 2019 Jan 09, 2020	BUY	$72.13 - $90.25 $1,947 - $2,436	27 Added 3.85%	728 $64,000
Q3 2019 Oct 21, 2019	BUY	$62.98 - $75.72 $6,738 - $8,102	107 Added 18.01%	701 $53,000
Q2 2019 Jul 23, 2019	SELL	$65.7 - $83.98 $18,855 - $24,102	-287 Reduced 32.58%	594 $43,000
Q1 2019 Apr 16, 2019	SELL	$77.14 - $90.79 $6,325 - $7,444	-82 Reduced 8.52%	881 $71,000
Q4 2018 Jan 11, 2019	SELL	$77.85 - $96.01 $661,569 - $815,892	-8,498 Reduced 89.82%	963 $89,000
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $85,798 - $95,380	-965 Reduced 9.26%	9,461 $895,000
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $23,612 - $27,938	-263 Reduced 2.46%	10,426 $966,000
Q1 2018 Apr 13, 2018	SELL	$92.01 - $123.21 $119,520 - $160,049	-1,299 Reduced 10.84%	10,689 $1.01 Million
Q4 2017 Jan 11, 2018	BUY	$89.56 - $98.21 $12,717 - $13,945	142 Added 1.2%	11,988 $1.16 Million
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $827,443 - $1.06 Million	11,846	11,846 $1.05 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kessler Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kessler Investment Group, LLC with notifications on news.

Account

Kessler Investment Group, LLC Abb Vie Inc. Transaction History